Janus Henderson Group PLC Heron Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $40,448 - $87,057	26,787 Added 151.01%	44,526 $67,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $4 - $9	2 Added 0.01%	17,739 $44,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $122 - $247	46 Added 0.26%	17,737 $75,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $89 - $245	-39 Reduced 0.22%	17,691 $50,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $82,089 - $176,236	17,730 New	17,730 $102,000
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $6.78 Million - $10.3 Million	-464,301 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $2.96 Million - $3.85 Million	-216,454 Reduced 31.8%	464,301 $6.88 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $27.1 Million - $53.4 Million	-2,489,265 Reduced 78.53%	680,755 $10 Million
Q1 2020 May 14, 2020	SELL	$10.23 - $24.56 $17.9 Million - $42.9 Million	-1,745,293 Reduced 35.51%	3,170,020 $37.2 Million
Q4 2019 Feb 18, 2020	SELL	$17.42 - $26.61 $3.73 Million - $5.7 Million	-214,028 Reduced 4.17%	4,915,313 $116 Million
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $320,934 - $419,607	19,617 Added 0.38%	5,129,341 $94.9 Million
Q2 2019 Jul 31, 2019	SELL	$16.93 - $26.22 $1.49 Million - $2.31 Million	-87,951 Reduced 1.69%	5,109,724 $95 Million
Q1 2019 Apr 30, 2019	SELL	$23.15 - $28.34 $5.55 Million - $6.8 Million	-239,865 Reduced 4.41%	5,197,675 $127 Million
Q4 2018 Feb 06, 2019	BUY	$22.03 - $32.01 $232,394 - $337,673	10,549 Added 0.19%	5,437,540 $141 Million
Q3 2018 Nov 09, 2018	SELL	$30.0 - $40.85 $13.3 Million - $18.1 Million	-443,819 Reduced 7.56%	5,426,991 $172 Million
Q2 2018 Aug 10, 2018	SELL	$26.4 - $42.0 $56.8 Million - $90.3 Million	-2,150,540 Reduced 26.81%	5,870,810 $228 Million
Q1 2018 May 14, 2018	BUY	$18.43 - $28.8 $17.7 Million - $27.6 Million	959,488 Added 13.59%	8,021,350 $221 Million
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $19.2 Million - $24.4 Million	1,294,367 Added 22.44%	7,061,862 $128 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $1.85 Million - $2.12 Million	126,039 Added 2.23%	5,767,495 $0
Q2 2017 Aug 17, 2017	BUY	N/A	5,641,456	5,641,456 $78.1 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account